Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Development of a self-treatment approach for patients with COPD and comorbidities: an ongoing learning process|
van Ommeren, C.
van der Valk, P.
van der Palen, J.
|Citation:||Journal of Thoracic Disease, 2014; 6(11):1597-1605|
|Publisher:||Pioneer Bioscience Publishing|
|Tanja W. Effing, Anke Lenferink, Julie Buckman, Deborah Spicer, Paul A. Cafarella, Morton G. Burt, Katherine L. Bassett, Clara van Ommeren, Sally Anesbury, Paul D L P M van der Valk, Peter A. Frith, Job van der Palen|
|Abstract:||BACKGROUND: Patient-initiated action plans are an important component of COPD self-management (SM) interventions. When integrated into SM interventions, these action plans have proven to be effective in reducing exacerbation severity, hospitalisations, and costs and in improving health status in patients with COPD without severe comorbidities. Because of overlap in symptoms, a self-treatment (ST) approach that focuses solely on traditional symptoms of COPD is inadequate for patients with COPD and comorbidities. The COPE-III SM intervention combines (I) patient-initiated action plans that are tailored to the individual's co-morbid disease(s), and (II) ongoing nurse support. In this paper we provide information regarding the integration of information from two previous COPD SM studies (COPE I and II) in the development of the current COPE-III ST approach. MATERIALS AND METHODS: COPE-III ST materials include daily symptom diaries and action plans that take patient's common comorbidities [chronic heart failure (CHF), anxiety, depression, ischaemic heart disease (IHD), and diabetes] into account. The comorbid diary and action plans components were developed in collaboration with multiple disease-experts. RESULTS: Previous SM studies have highlighted some essential topics that need to be considered when developing a SM or ST approach: 'when to initiate ST', 'how to optimize materials and safety', and 'how to achieve behavioural change'. In the COPE-III study, ST is initiated after a significant change in symptoms. This is consistent with the COPE-II approach and was implemented because disease symptoms are often present even when patients are stable. We have tried to ensure patient safety by providing an easily accessible case-manager to patients throughout their involvement in the study. Furthermore, a psychologist has ensured the use of behavioural change techniques throughout the intervention. CONCLUSIONS: We should continue to learn from our experiences with SM interventions to further optimize future SM and ST interventions. The use of materials that are suitable for different levels of patient literacy and the training of health care providers are other points of improvement.|
|Keywords:||Pulmonary disease; chronic obstructive; comorbidity; self-care|
|Rights:||© Pioneer Bioscience Publishing Company. All rights reserved.|
|Appears in Collections:||Nursing publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.